GPER1 and breast cancer: In this study, we have identified a novel antagonist ligand of GPER, namely C4PY, which exhibits an inhibitory action on GPER-activated signaling, including the repression of both ERK and Akt phosphorylation, gene transcription, and cell proliferation and migration in breast cancer cells and in CAFs.